SUD Archives - Page 3 of 5

The Authors’ Own Words: Outpatient Continuing Care after Residential Substance Use Disorder Treatment in the U.S. Veterans Health Administration: Facilitators and Challenges

Jan 21, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Outpatient Continuing Care after Residential Substance Use Disorder Treatment in the U.S. Veterans Health Administration: Facilitators and Challenges

Anna D. Rubinsky, PhD, MS; Laura S. Ellerbe, MS; Shalini Gupta, MS; Tyler E. Phelps, MLIS, MS; Thomas Bowe, PhD; Jennifer L. Burden, PhD; & Alex H. S. Harris, PhD, MS

Substance Abuse Vol. 39, Iss. 3, 2018

“We found wide variation in rates of outpatient continuing care across VHA’s 97 residential SUD treatment programs, despite policy requirements for follow-up care within a week of discharge, suggesting substantial opportunity for quality improvement. These findings also suggest that administrative data-based metrics could be useful for monitoring SUD continuing care following residential treatment. Moreover, this study identified key facilitators of and barriers to SUD continuing care. The candidate “best practices” from high-performing programs could inform the design and testing of targeted quality improvement strategies to improve rates of SUD continuing care, particularly in low-performing programs that may be high-value targets for quality improvement.”

The Authors’ Own Words: Addressing substance use disorder in primary care: The role, integration, and impact of recovery coaches

Jan 20, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Addressing substance use disorder in primary care: The role, integration, and impact of recovery coaches

Helen E. Jack, BA; Devin Oller, MD; John Kelly, PhD; Jessica F. Magidson, PhD; & Sarah E. Wakeman, MD

Substance Abuse Vol. 39, Iss. 3, 2018

“This paper uses qualitative interviews with recovery coaches and patients to define the role of recovery coaches, an emerging workforce in addiction treatment that has great potential to help expand access to substance use disorder treatment in primary care. It highlights the components of the recovery coach role and the benefits and challenges of incorporating recovery coaches into the interdisciplinary primary care team. This study is one of few to examine recovery coaches and the first to use patient and coach perspectives to understand the recovery coach role.”

The Authors’ Own Words: Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Training drug addiction counselors to deliver a brief psychosocial psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigation.

Jan 7, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Training drug addiction counselors to deliver a brief psychosocial psychoeducational intervention for chronic pain among patients in opioid agonist treatment: A pilot investigation.

Jenna L. Butner MD; Curtis Bone MD; Caridad C. Ponce Martinez MD; Grace Kwon MD; Mark Beitel PhD; Lynn M. Madden PhD; Madeline H. Bono; Anthony Eller BS; & Declan T. Barry PhD

Substance Abuse Vol. 39, Iss. 2, 2018

“Initiatives to reduce providers’ perceived inability, reported discomfort, and lack of interest in managing chronic pain have centered on enhancing curricula at medical and professional schools. This approach has met with mixed success; it appears that training providers on a biomedical model of pain management emphasizing pathophysiology, pharmacotherapy, and surgical interventions does not automatically enhance perceived ability to manage chronic pain. Findings from this pilot study suggest that it is both feasible and acceptable to train front-line opioid agonist treatment drug counselors with an inexpensive, brief, onsite psychoeducational intervention for assessing and addressing chronic pain; on average attendees continued to perceive a beneficial effect on their clinical work with patients six months later. These findings underscore the importance of conducting further research on training providers, including those in opioid agonist treatment settings, on the biopsychosocial model of chronic pain, and targeting strategies that might enhance their clinical management of patients with chronic pain.”

The Authors’ Own Words: Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy

Jan 6, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Integration of a Clinical Pharmacy Specialist into a Substance Use Disorder Intensive Outpatient Treatment Program to Improve Prescribing Rates of Alcohol Use Disorder Pharmacotherapy

Erica Dimitropoulos PharmD, Stephanie Bertucci LICSW; & Kara Wong PharmD, BCPP

Substance Abuse Vol. 39, Iss. 2, 2018

“The pharmacist’s role in the management of substance use disorders is not currently well defined. In an effort to explore this further, our study employed a bridge service that utilized pharmacists to improve access to evidence-based alcohol use disorder pharmacotherapy. Using this model, we were able to optimize treatment by offering medications to supplement psychotherapy for patients enrolled in an intensive outpatient program. Our intervention serves as an example for other facilities looking for novel ways to integrate pharmacists into substance use disorder clinics.”

The Authors’ Own Words: Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned

Jan 3, 2020 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned

Sean M. Murphy PhD; Jared A. Leff MS; Benjamin P. Linas MD, MPH; Jake R. Morgan PhD; Kathryn McCollister PhD; & Bruce R. Schackman PhD

Substance Abuse Vol. 39, Iss. 2, 2018

“Both effectiveness and costs must be taken into consideration to successfully reach the greatest number of individuals and match them with the best interventions; however, health-economic researchers with expertise in substance use disorders and related conditions can be difficult to find. The Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV (CHERISH) designed a free consultation service for investigators whose work aligns with CHERISH’s mission of developing and disseminating health-economic research on healthcare utilization, health outcomes, and health-related behaviors that informs substance use disorder treatment policy, and HCV and HIV care of people who use substances. The Consultation Service serves as a resource to ensure that economic analyses are appropriately designed, methodologically sound, and feasible, and that outcomes are correctly interpreted.”